NZ Herald
  • Home
  • Latest news
  • Herald NOW
  • Video
  • New Zealand
  • Sport
  • World
  • Business
  • Entertainment
  • Podcasts
  • Quizzes
  • Opinion
  • Lifestyle
  • Travel
  • Viva
  • Weather

Subscriptions

  • Herald Premium
  • Viva Premium
  • The Listener
  • BusinessDesk

Sections

  • Latest news
  • New Zealand
    • All New Zealand
    • Crime
    • Politics
    • Education
    • Open Justice
    • Scam Update
  • Herald NOW
  • On The Up
  • World
    • All World
    • Australia
    • Asia
    • UK
    • United States
    • Middle East
    • Europe
    • Pacific
  • Business
    • All Business
    • MarketsSharesCurrencyCommoditiesStock TakesCrypto
    • Markets with Madison
    • Media Insider
    • Business analysis
    • Personal financeKiwiSaverInterest ratesTaxInvestment
    • EconomyInflationGDPOfficial cash rateEmployment
    • Small business
    • Business reportsMood of the BoardroomProject AucklandSustainable business and financeCapital markets reportAgribusiness reportInfrastructure reportDynamic business
    • Deloitte Top 200 Awards
    • CompaniesAged CareAgribusinessAirlinesBanking and financeConstructionEnergyFreight and logisticsHealthcareManufacturingMedia and MarketingRetailTelecommunicationsTourism
  • Opinion
    • All Opinion
    • Analysis
    • Editorials
    • Business analysis
    • Premium opinion
    • Letters to the editor
  • Politics
  • Sport
    • All Sport
    • OlympicsParalympics
    • RugbySuper RugbyNPCAll BlacksBlack FernsRugby sevensSchool rugby
    • CricketBlack CapsWhite Ferns
    • Racing
    • NetballSilver Ferns
    • LeagueWarriorsNRL
    • FootballWellington PhoenixAuckland FCAll WhitesFootball FernsEnglish Premier League
    • GolfNZ Open
    • MotorsportFormula 1
    • Boxing
    • UFC
    • BasketballNBABreakersTall BlacksTall Ferns
    • Tennis
    • Cycling
    • Athletics
    • SailingAmerica's CupSailGP
    • Rowing
  • Lifestyle
    • All Lifestyle
    • Viva - Food, fashion & beauty
    • Society Insider
    • Royals
    • Sex & relationships
    • Food & drinkRecipesRecipe collectionsRestaurant reviewsRestaurant bookings
    • Health & wellbeing
    • Fashion & beauty
    • Pets & animals
    • The Selection - Shop the trendsShop fashionShop beautyShop entertainmentShop giftsShop home & living
    • Milford's Investing Place
  • Entertainment
    • All Entertainment
    • TV
    • MoviesMovie reviews
    • MusicMusic reviews
    • BooksBook reviews
    • Culture
    • ReviewsBook reviewsMovie reviewsMusic reviewsRestaurant reviews
  • Travel
    • All Travel
    • News
    • New ZealandNorthlandAucklandWellingtonCanterburyOtago / QueenstownNelson-TasmanBest NZ beaches
    • International travelAustraliaPacific IslandsEuropeUKUSAAfricaAsia
    • Rail holidays
    • Cruise holidays
    • Ski holidays
    • Luxury travel
    • Adventure travel
  • Kāhu Māori news
  • Environment
    • All Environment
    • Our Green Future
  • Talanoa Pacific news
  • Property
    • All Property
    • Property Insider
    • Interest rates tracker
    • Residential property listings
    • Commercial property listings
  • Health
  • Technology
    • All Technology
    • AI
    • Social media
  • Rural
    • All Rural
    • Dairy farming
    • Sheep & beef farming
    • Horticulture
    • Animal health
    • Rural business
    • Rural life
    • Rural technology
    • Opinion
    • Audio & podcasts
  • Weather forecasts
    • All Weather forecasts
    • Kaitaia
    • Whangārei
    • Dargaville
    • Auckland
    • Thames
    • Tauranga
    • Hamilton
    • Whakatāne
    • Rotorua
    • Tokoroa
    • Te Kuiti
    • Taumaranui
    • Taupō
    • Gisborne
    • New Plymouth
    • Napier
    • Hastings
    • Dannevirke
    • Whanganui
    • Palmerston North
    • Levin
    • Paraparaumu
    • Masterton
    • Wellington
    • Motueka
    • Nelson
    • Blenheim
    • Westport
    • Reefton
    • Kaikōura
    • Greymouth
    • Hokitika
    • Christchurch
    • Ashburton
    • Timaru
    • Wānaka
    • Oamaru
    • Queenstown
    • Dunedin
    • Gore
    • Invercargill
  • Meet the journalists
  • Promotions & competitions
  • OneRoof property listings
  • Driven car news

Puzzles & Quizzes

  • Puzzles
    • All Puzzles
    • Sudoku
    • Code Cracker
    • Crosswords
    • Cryptic crossword
    • Wordsearch
  • Quizzes
    • All Quizzes
    • Morning quiz
    • Afternoon quiz
    • Sports quiz

Regions

  • Northland
    • All Northland
    • Far North
    • Kaitaia
    • Kerikeri
    • Kaikohe
    • Bay of Islands
    • Whangarei
    • Dargaville
    • Kaipara
    • Mangawhai
  • Auckland
  • Waikato
    • All Waikato
    • Hamilton
    • Coromandel & Hauraki
    • Matamata & Piako
    • Cambridge
    • Te Awamutu
    • Tokoroa & South Waikato
    • Taupō & Tūrangi
  • Bay of Plenty
    • All Bay of Plenty
    • Katikati
    • Tauranga
    • Mount Maunganui
    • Pāpāmoa
    • Te Puke
    • Whakatāne
  • Rotorua
  • Hawke's Bay
    • All Hawke's Bay
    • Napier
    • Hastings
    • Havelock North
    • Central Hawke's Bay
    • Wairoa
  • Taranaki
    • All Taranaki
    • Stratford
    • New Plymouth
    • Hāwera
  • Manawatū - Whanganui
    • All Manawatū - Whanganui
    • Whanganui
    • Palmerston North
    • Manawatū
    • Tararua
    • Horowhenua
  • Wellington
    • All Wellington
    • Kapiti
    • Wairarapa
    • Upper Hutt
    • Lower Hutt
  • Nelson & Tasman
    • All Nelson & Tasman
    • Motueka
    • Nelson
    • Tasman
  • Marlborough
  • West Coast
  • Canterbury
    • All Canterbury
    • Kaikōura
    • Christchurch
    • Ashburton
    • Timaru
  • Otago
    • All Otago
    • Oamaru
    • Dunedin
    • Balclutha
    • Alexandra
    • Queenstown
    • Wanaka
  • Southland
    • All Southland
    • Invercargill
    • Gore
    • Stewart Island
  • Gisborne

Media

  • Video
    • All Video
    • NZ news video
    • Herald NOW
    • Business news video
    • Politics news video
    • Sport video
    • World news video
    • Lifestyle video
    • Entertainment video
    • Travel video
    • Markets with Madison
    • Kea Kids news
  • Podcasts
    • All Podcasts
    • The Front Page
    • On the Tiles
    • Ask me Anything
    • The Little Things
  • Cartoons
  • Photo galleries
  • Today's Paper - E-editions
  • Photo sales
  • Classifieds

NZME Network

  • Advertise with NZME
  • OneRoof
  • Driven Car Guide
  • BusinessDesk
  • Newstalk ZB
  • Sunlive
  • ZM
  • The Hits
  • Coast
  • Radio Hauraki
  • The Alternative Commentary Collective
  • Gold
  • Flava
  • iHeart Radio
  • Hokonui
  • Radio Wanaka
  • iHeartCountry New Zealand
  • Restaurant Hub
  • NZME Events

SubscribeSign In

Advertisement
Advertise with NZME.
Home / World

Covid 19 coronavirus: Johnson & Johnson's one-shot vaccine gets US approval; 5 million doses on order for NZ

By Lauren Neergaard and Matthew Perrone
AP·
27 Feb, 2021 11:50 PM6 mins to read

Subscribe to listen

Access to Herald Premium articles require a Premium subscription. Subscribe now to listen.
Already a subscriber?  Sign in here

Listening to articles is free for open-access content—explore other articles or learn more about text-to-speech.
‌
Save

    Share this article

Just the facts - A closer look at the Covid-19 vaccine being rolled out across Aotearoa. How it works, why we need it and who developed it. Video / NZ Herald

The US has approved a third vaccine to prevent Covid-19, as the Food and Drug Administration today cleared a Johnson & Johnson shot that works with just one dose instead of two.

New Zealand's Government has signed an in-principle agreement to purchase up to 5 million doses of the vaccine, which was developed by Janssen Pharmaceutica, a Belgium-based division of Johnson & Johnson.

NZ has also signed agreements with Pfizer (up to 1.5m doses), Novavax ((10.72m doses) and AstraZeneca (7.6m doses) - all of which require two shots.

Health experts are anxiously awaiting a one-and-done option to help speed vaccinations, as they race against a virus that has already killed more than 2.5 million people worldwide and is mutating in increasingly worrisome ways.

Advertisement
Advertise with NZME.
Advertisement
Advertise with NZME.

The FDA said J&J's vaccine offers strong protection against what matters most: serious illness, hospitalisations and death. One dose was 85 per cent protective against the most severe Covid-19 illness in a massive study that spanned three continents — protection that remained strong even in countries such as South Africa, where the variants of most concern are spreading.

"This is really good news," said Dr Francis Collins, director of the National Institutes of Health. "The most important thing we can do right now is to get as many shots in as many arms as we can."

J&J initially is providing a few million doses to the US and shipments to states could begin as early as Tuesday NZT. By the end of March, J&J has said, it expects to deliver 20 million doses to the US, and 100 million by their summer.

J&J also is seeking authorisation for emergency use of its vaccine in Europe and from the World Health Organisation. Worldwide, the company aims to produce about 1 billion doses globally by the end of the year. On Thursday, the island nation of Bahrain became the first to clear its use.

Advertisement
Advertise with NZME.
Then US-President-elect Joe Biden receives his first dose of the Pfizer coronavirus vaccine on December 21. Photo / AP
Then US-President-elect Joe Biden receives his first dose of the Pfizer coronavirus vaccine on December 21. Photo / AP

"This is exciting news for all Americans, and an encouraging development in our efforts to bring an end to the crisis," US President Joe Biden said in a statement. "But I want to be clear: this fight is far from over," he added, encouraging people to stick with masks and other public health measures.

A US advisory committee will meet tomorrow to recommend how to prioritise use of the single-dose vaccine. And one big challenge is what the public wants to know: which kind is better?

"In this environment, whatever you can get — get," said Dr Arnold Monto of the University of Michigan, who chaired an FDA advisory panel that unanimously voted yesterday that the vaccine's benefits outweigh its risks.

Data is mixed on how well all the vaccines being used around the world work, prompting reports in some countries of people refusing one kind to wait for another.

Discover more

Business

Community helps bakery after 'nightmare' lockdown call

27 Feb 11:31 PM
New Zealand

'S***ty thing to do': Dr Siouxsie Wiles blasts fleeing Aucklanders

27 Feb 10:45 PM
New Zealand

Covid-19: Chaos at Auckland Airport, long queues around terminal

27 Feb 09:55 PM
New Zealand

Anger at breach, fears about 'conspiracy theories' during lockdown

27 Feb 11:15 PM

In the US, the two-dose Pfizer and Moderna shots were 95 per cent protective against symptomatic Covid-19. J&J's one-dose effectiveness of 85 per cent against severe Covid-19 dropped to 66 per cent when moderate cases were rolled in.

But there's no apples-to-apples comparison because of differences in when and where each company conducted its studies, with the Pfizer and Moderna research finished before concerning variants began spreading.

The NIH's Collins said the evidence shows no reason to favour one vaccine over another.

"What people I think are mostly interested in is, is it going to keep me from getting really sick?" Collins said. "Will it keep me from dying from this terrible disease? The good news is all of these say yes to that."

Also, J&J is testing two doses of its vaccine in a separate large study. Collins said if a second dose eventually is deemed better, people who got one earlier would be offered another.

The FDA cautioned that it's too early to tell if someone who gets a mild or asymptomatic infection despite vaccination still could spread the virus.

Advertisement
Advertise with NZME.

There are clear advantages aside from the convenience of one shot. Local health officials are looking to use the J&J option in mobile vaccination clinics, homeless shelters, even with sailors who are spending months on fishing vessels — communities where it's hard to be sure someone will come back in three to four weeks for a second vaccination.

The J&J vaccine is also easier to handle, lasting three months in the refrigerator compared to the Pfizer and Moderna options, which must be frozen.

"We're chomping at the bit to get more supply. That's the limiting factor for us right now," said Dr Matt Anderson of UW Health in Madison, Wisconsin.

The FDA said studies detected no serious side effects. Like other Covid-19 vaccines, the main side effects of the J&J shot are pain at the injection site and flu-like fever, fatigue and headache.

An FDA fact sheet for vaccine recipients says there is "a remote chance" that people may experience a severe allergic reaction to the shot, a rare risk seen with the Pfizer and Moderna vaccines. Such reactions are treatable, and vaccine recipients are supposed to be briefly monitored after the injection.

The vaccine has been authorised for emergency use in the US in adults 18 and older for now. But like other manufacturers, J&J is about to study how it works in teens before moving to younger children later in the year, and also plans a study in pregnant women.

Advertisement
Advertise with NZME.

How the vaccines work

All Covid-19 vaccines train the body to recognise the new coronavirus, usually by spotting the spiky protein that coats it. But they're made in very different ways.

J&J's shot uses a cold virus like a Trojan horse to carry the spike gene into the body, where cells make harmless copies of the protein to prime the immune system in case the real virus comes along. It's the same technology the company used in making an Ebola vaccine, and similar to Covid-19 vaccines made by AstraZeneca and China's CanSino Biologics.

The Pfizer and Moderna vaccines are made with a different technology, a piece of genetic code called messenger RNA that spurs cells to make those harmless spike copies.

The AstraZeneca vaccine, already used in Britain and numerous other countries, is finishing a large US study needed for FDA clearance.

Also in the pipeline, Novavax uses a still different technology, made with lab-grown copies of the spike protein, and has reported preliminary findings from a British study suggesting strong protection.

Still other countries are using "inactivated vaccines" made with killed coronavirus by Chinese companies Sinovac and Sinopharm.

Advertisement
Advertise with NZME.
Save

    Share this article

Latest from New Zealand

New Zealand

'Moving quite quickly': Fresh bout of wild weather to sweep across top of North Island

New Zealand

Missing Upper Hutt man found 'safe and well'

Wellington

Chung’s campaign group loses candidate amid email scandal


Sponsored

Solar bat monitors uncover secrets of Auckland’s night sky

Advertisement
Advertise with NZME.

Latest from New Zealand

'Moving quite quickly': Fresh bout of wild weather to sweep across top of North Island
New Zealand

'Moving quite quickly': Fresh bout of wild weather to sweep across top of North Island

Heavy rain watches have been issued for Northland and Auckland from early tomorrow.

16 Jul 09:13 AM
Missing Upper Hutt man found 'safe and well'
New Zealand

Missing Upper Hutt man found 'safe and well'

16 Jul 08:37 AM
Chung’s campaign group loses candidate amid email scandal
Wellington

Chung’s campaign group loses candidate amid email scandal

16 Jul 08:10 AM


Solar bat monitors uncover secrets of Auckland’s night sky
Sponsored

Solar bat monitors uncover secrets of Auckland’s night sky

06 Jul 09:47 PM
NZ Herald
  • About NZ Herald
  • Meet the journalists
  • Newsletters
  • Classifieds
  • Help & support
  • Contact us
  • House rules
  • Privacy Policy
  • Terms of use
  • Competition terms & conditions
  • Our use of AI
Subscriber Services
  • NZ Herald e-editions
  • Daily puzzles & quizzes
  • Manage your digital subscription
  • Manage your print subscription
  • Subscribe to the NZ Herald newspaper
  • Subscribe to Herald Premium
  • Gift a subscription
  • Subscriber FAQs
  • Subscription terms & conditions
  • Promotions and subscriber benefits
NZME Network
  • The New Zealand Herald
  • The Northland Age
  • The Northern Advocate
  • Waikato Herald
  • Bay of Plenty Times
  • Rotorua Daily Post
  • Hawke's Bay Today
  • Whanganui Chronicle
  • Viva
  • NZ Listener
  • Newstalk ZB
  • BusinessDesk
  • OneRoof
  • Driven Car Guide
  • iHeart Radio
  • Restaurant Hub
NZME
  • About NZME
  • NZME careers
  • Advertise with NZME
  • Digital self-service advertising
  • Book your classified ad
  • Photo sales
  • NZME Events
  • © Copyright 2025 NZME Publishing Limited
TOP